• Skip to primary navigation
  • Skip to main content

National Forum

  • Home
  • About
    • Annual Business Meeting
    • 2026-27 Strategic Plan
    • National Forum Awards
    • Advisory Leadership Council
    • Board of Directors
    • A Public Health Action Plan to Prevent Heart Disease & Stroke
    • Team
    • Support
    • Careers
  • Collaborations
    • Awareness Months 2026
    • Community Pharmacists
    • Counter Cholesterol®
    • Hypertension Takedown™
    • Flu Prevention
    • Know Your Numbers
    • Million Hearts®
      • Million Hearts® Stakeholders Flu Vaccination Campaign
    • Move with the Mayor®
    • MWTM Cholesterol
    • MWTM Flu Immunization
    • Signature Reports
    • Stronger Hearts™
    • Value & Access
      • Shared Decision Guide-High Cholesterol
      • Shared Decision Guide-AFib
      • Resources
      • Joint Policy Statements
    • Value & Innovation Forum
  • Events
    • National Forum and Member Events
    • 2026 Annual Meeting – Unleashing Prevention’s Power: Improving Americans’ Heart, Kidney, Metabolic, and Brain Health
    • 2026 NF Discussion on Key Takeaways from the 2026​ Guideline on the Management of Dyslipidemia
    • 2026 Unseen and Untreated: Confronting the Connections Between Heart and Kidney Disease
    • 2026 Mid-Year Virtual Convening-Unleashing Prevention’s Power: Hypertension Takedown™
    • 2025 Annual Meeting – Championing a Heart-Healthy America
    • 2025 NF Discussion on New AHA/ACC High Blood Pressure Guideline
    • 2025 Mid-Year Virtual Convening – Hypertension Takedown™
    • 2025 Vital Conditions Office Hour with Dr. Bobby Milstein
    • Value & Access Briefings
    • Physical Activity, Fitness and Stretch Breaks
  • Members
    • Join the National Forum
  • Newsroom
  • Search Toggle
  • Skip to content

COVID-19 and People with Heart Disease: 3.27.20 Update

Posted on 03.27.20

Dear National Forum Members, Stakeholders, and Mayors in Move with the Mayor™,

CDC this afternoon gave a briefing on people who are at higher risk for severe illness from COVID-19. The briefer reported that, “Data clearly show people at older ages have higher risk.” This includes people over age 50, especially those over 65. Additionally, people of all ages who have underlying medical conditions, including “serious heart conditions … and diabetes,” “… especially where the conditions are not well-controlled” are at higher risk.

Who exactly do they mean?

CDC said there is insufficient evidence today to specify which severe heart conditions are included. They added, based on the limited data available so far, it appears people with heart failure, coronary artery disease, genetic heart disease, and pulmonary hypertension may have higher risk for severe illness.

The bottom line on hypertension treatment is, “Stay the course,” the briefer said. CDC is “seeing an association epidemiologically with hypertension” but does not yet have enough evidence to tell whether people with hypertension alone are at greater risk for severe illness. CDC’s advice for people being treated for hypertension is to continue taking their medications as directed by their healthcare providers.

CDC’s latest guidance is available by clicking here. The American College of Cardiology, American Heart Association and Heart Failure Society of America jointly issued advice on the treatment of people with hypertension and heart failure. CDC will update its guidance as new evidence becomes available and the National Forum will keep you informed.

I hope you are well and stay that way.

Sincerely,

John M. Clymer
Executive Director
National Forum for Heart Disease & Stroke Prevention

Categories: Blog, In the News, News Releases

Subscribe Here for National Forum
Meetings, Events, and Updates

1717 Pennsylvania Avenue, NW, Suite 1025, 10th Floor Washington, DC 20006
Phone: (866) 894-3500 Fax: (202) 330-5080
  • Legal
  • Financial
  • Sitemap
Copyright © 2026 National Forum for Heart Disease & Stroke Prevention. All Rights Reserved
  • Facebook
  • Twitter
  • YouTube
  • Instagram
Contact

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*